Skip to main content
Erschienen in: Familial Cancer 2/2010

01.06.2010

Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient

verfasst von: Ismail Alrashdi, Samantha Levine, Joan Paterson, Rohit Saxena, Soonie R. Patel, Sarita Depani, Darren R. Hargrave, Kathy Pritchard-Jones, Shirley V. Hodgson

Erschienen in: Familial Cancer | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Hereditary leiomyomatosis and renal cell cancer is a hereditary cancer syndrome in which affected individuals are at risk for cutaneous and uterine leiomyomas, and renal cancer. Previous reports have stressed the aggressiveness of the renal tumours, often with early metastasis, despite small primary tumour size. Almost all the previously reported patients were adults, and different studies showed variability in penetrance for the renal tumours. We report a patient in whom renal cancer was detected at the age of 11 years at his first routine screening imaging after he was found to carry a fumarate hydratase gene mutation (c.1189G > A) transmitted from his mother. This report serves to emphasize the need to improve guidelines for screening of at risk individuals, including the necessity for predictive genetic testing and early institution of tumour surveillance in childhood.
Literatur
1.
Zurück zum Zitat Launonen V, Vierimaa O, Kiuru M et al (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98:3387–3392CrossRefPubMed Launonen V, Vierimaa O, Kiuru M et al (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98:3387–3392CrossRefPubMed
2.
Zurück zum Zitat Alam NA, Bevan S, Churchman M et al (2001) Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3–q43. Am J Hum Genet 68:1264–1269CrossRefPubMed Alam NA, Bevan S, Churchman M et al (2001) Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3–q43. Am J Hum Genet 68:1264–1269CrossRefPubMed
3.
Zurück zum Zitat Tomlinson IP, Alam NA, Rowan AJ et al (2003) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410CrossRef Tomlinson IP, Alam NA, Rowan AJ et al (2003) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410CrossRef
4.
Zurück zum Zitat Bayley JP, Launonen V, Tomlinson IP (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9:20CrossRefPubMed Bayley JP, Launonen V, Tomlinson IP (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9:20CrossRefPubMed
5.
Zurück zum Zitat Toro JR, Nickerson ML, Wei MH et al (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95–106CrossRefPubMed Toro JR, Nickerson ML, Wei MH et al (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95–106CrossRefPubMed
6.
Zurück zum Zitat Alam NA, Olpin S, Leigh IM (2005) Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 153:11–17CrossRefPubMed Alam NA, Olpin S, Leigh IM (2005) Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 153:11–17CrossRefPubMed
7.
Zurück zum Zitat Wei MH, Toure O, Glenn GM et al (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18–27CrossRefPubMed Wei MH, Toure O, Glenn GM et al (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18–27CrossRefPubMed
8.
Zurück zum Zitat Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumors. J Pathol 183:131–133CrossRefPubMed Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumors. J Pathol 183:131–133CrossRefPubMed
9.
Zurück zum Zitat Merino MJ, Torres-Cabala C, Pinto P et al (2007) The morphologic spectrum of kidney tumours in hereditary leiomyomatosis and renal cell cancer syndrome. Am J Surg Pathol 31:1578–1585CrossRefPubMed Merino MJ, Torres-Cabala C, Pinto P et al (2007) The morphologic spectrum of kidney tumours in hereditary leiomyomatosis and renal cell cancer syndrome. Am J Surg Pathol 31:1578–1585CrossRefPubMed
10.
Zurück zum Zitat Refae MA, Wong N, Patenaude F et al (2007) Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 4:256–261CrossRefPubMed Refae MA, Wong N, Patenaude F et al (2007) Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 4:256–261CrossRefPubMed
11.
Zurück zum Zitat Alam NA, Rowan AJ, Wortham NC et al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12(11):1241–1252CrossRefPubMed Alam NA, Rowan AJ, Wortham NC et al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12(11):1241–1252CrossRefPubMed
12.
Zurück zum Zitat Badeloe S, Van Spaendonck-Zwarts KY, Van Steensel MA et al (2009) Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer? Br J Dermatol 160(3):707–709CrossRefPubMed Badeloe S, Van Spaendonck-Zwarts KY, Van Steensel MA et al (2009) Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer? Br J Dermatol 160(3):707–709CrossRefPubMed
13.
Zurück zum Zitat Lehtonen HJ, Kiuru M, Ylisaukko-oja SK et al (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523–526CrossRefPubMed Lehtonen HJ, Kiuru M, Ylisaukko-oja SK et al (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523–526CrossRefPubMed
14.
Zurück zum Zitat Johnston LB, Chew SL, Trainer PJ et al (2000) Screening children at risk of developing inherited endocrine neoplasia syndromes. Clin Endocrinol 52(2):127–136CrossRef Johnston LB, Chew SL, Trainer PJ et al (2000) Screening children at risk of developing inherited endocrine neoplasia syndromes. Clin Endocrinol 52(2):127–136CrossRef
Metadaten
Titel
Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient
verfasst von
Ismail Alrashdi
Samantha Levine
Joan Paterson
Rohit Saxena
Soonie R. Patel
Sarita Depani
Darren R. Hargrave
Kathy Pritchard-Jones
Shirley V. Hodgson
Publikationsdatum
01.06.2010
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 2/2010
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-009-9306-0

Weitere Artikel der Ausgabe 2/2010

Familial Cancer 2/2010 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.